EMBL

Rajat Bhatnagar, a Quality Assurance Automation Engineer, discusses how test automation ensures Europe PMC works well for its users.

Scientists have found how phages, viruses that infect bacteria, effectively set off an explosion of protein modifications inside host cells that helps them evade the bacteria’s immune system.

Antimicrobial resistance (AMR) Portal updated with new search, genome browser and annotations

Researchers at EMBL analysed the protein degradation rate of around 4,000 genes. Their findings help explain why human embryonic development is slower than mouse embryonic development.

The Rfam database has been a cornerstone resource for RNA sequence families for over two decades. When the team began planning a redesign, they saw an opportunity to put AI tools to the test. Philippa Muston, Full Stack Developer at EMBL-EBI shares her team’s experience and learnings from the process.  About Rfam The Rfam databa…

EMBL’s new Head of Scientific Instrumentation Workshops discusses how building customised experimental setups can enable exciting new research.

Public Engagement Officer Sam Shingles discusses the importance of two-way conversations for sharing science with the wider public.

New ‘teaming’ projects in genomic medicine and wastewater monitoring will serve important research needs in Portugal and Latvia.

A landmark alliance of DNA experts across Europe signals the start of an effort to build a continent-wide system that applies genomics to protecting European biodiversity.

EMBL alumna Lisa Maier, recipient of the 2026 John Kendrew Award, discusses her scientific achievements, the importance of science engagement, and how she carries on the ‘EMBL spirit’

Researchers use synthetic biology approaches to test hundreds of DNA sequences for their effect on regulating gene expression.

RNAcentral 27 is now available, featuring circular RNAs, AI-ready data exports, a new MCP server, and over 55 million ncRNA sequences.

Researchers have found a new layer of control over DNA repair, one that operates outside the nucleus, at the Golgi complex.

Satellites can monitor tropical forests from above, but they cannot see the microbes beneath the soil. COMADRE brings these two worlds together to reveal a more complete picture of forest health.

How cancer develops and responds to treatment depends not only on the tumour cells themselves but also on the complex ecosystem of surrounding immune cells, blood vessels, and connective tissue. In B-cell non-Hodgkin lymphoma, these cellular neighbourhoods can determine whether a tumour grows,…

EMBL and Merck are bringing back the European Researchers’ Night to Heidelberg on 25 September 2026, with hands-on science, lab tours, art, and activities for all ages.

Epitome Therapeutics, a new EMBL spin-off, translates epigenome editing research into precision medicines. Co-founded by EMBL group leader Jamie Hackett, the company builds on pioneering research from EMBL Rome to open new possibilities for treating diseases caused by dysregulated gene expression.

The latest version of the MGnify service introduces updated analysis pipelines, a redesigned website, and faster access to metagenomic analysis results.

EMBL Hamburg researchers and their collaborators have gained new insights into how the influenza A virus reprograms cellular machinery by tracking molecular interactions directly inside infected cells.

Researchers have designed synthetic and inducible proteins that bind to bright fluorescent dyes with high specificity and affinity, significantly expanding the toolkit for multicolour imaging of proteins inside cells.